Pharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while talent shorta...

Artificial intelligence skill demand in India's Contract Development and Manufacturing Organisation sector is set to surge. Demand for AI s...

Corporate India's March 2026 quarter results showed a mixed performance. While revenues grew strongly, input cost inflation and a weaker ru...

Over a dozen Indian companies have launched generic versions of the GLP1 drug used for diabetes and weight management since the expiry of N...

The war forced changes on quite a few fronts. First was a re-assessment of the “new-normal” for crude and on certain commodities where supp...

As global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.

India’s pharmaceutical industry faces a potential raw material crunch after the government restricted surplus ammonia supply to fertiliser ...

The ongoing conflict in Iran is impacting India's healthcare sector. Pharmaceutical distributors warn of significant price increases for es...

A US naval blockade of Iranian ports, following failed ceasefire talks, has increased uncertainty over energy cargo movements and the risk ...

India faces challenges with essential drug ingredient supplies. Geopolitical issues are impacting key solvents and feedstocks. However, dru...

Fifty pharmaceutical manufacturing facilities have shuttered their operations in Baddi, Himachal Pradesh, Asia’s largest pharmaceutical hub...

Indian companies are the main supplier of generic drugs to the world and procure almost 70% of the active pharmaceutical ingredients (APIs)...

Shaw said in the run up to the GST, pharmaceutical firms have taken a huge hit on their businesses in June as a result of pharmacists decli...

Sun Pharma is the most valuable pharma stocks as the company is expected to post a strong performance in the quarters ahead.

Shares of Sun Pharma rose 4% on Wednesday after the US drug regulator said it will import generic version of the cancer drug Lipidox.

The US said it will import cancer drug manufactured in India to overcome the acute shortage of the medicine used in treatment of ovarian, b...

Costly imports of ingredients from China may take 20% drugs off shelf.